Retraction: Endothelin-1 Inhibits Prolyl Hydroxylase Domain 2 to Activate Hypoxia-Inducible Factor-1α in Melanoma Cells.
        Saved in:
      
    
          | Main Author: | PLOS ONE Editors | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Public Library of Science (PLoS)
    
        2024-01-01 | 
| Series: | PLoS ONE | 
| Online Access: | https://doi.org/10.1371/journal.pone.0315282 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Hypertension Induced by Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitors in Treating Anemia in Patients With Chronic Kidney Disease: A Mini‐Review        
                          
 by: Wei Zhang, et al.
 Published: (2024-12-01)
- 
                
                    Retraction: Neuroprotective Role of Intermittent Hypobaric Hypoxia in Unpredictable Chronic Mild Stress Induced Depression in Rats.        
                          
 by: PLOS One Editors
 Published: (2025-01-01)
- 
                
                    Retraction: Nanocurcumin Prevents Hypoxia Induced Stress in Primary Human Ventricular Cardiomyocytes by Maintaining Mitochondrial Homeostasis.        
                          
 by: PLOS One Editors
 Published: (2025-01-01)
- 
                
                    Efficacy of Hypoxia-Inducible Factor Prolyl-Hydroxylase Inhibitors in Renal Anemia: Enhancing Erythropoiesis and Long-Term Outcomes in Patients with Chronic Kidney Disease        
                          
 by: Yukina Yoshida, et al.
 Published: (2024-12-01)
- 
                
                    Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in chronic kidney disease patients with renal anemia: a retrospective study        
                          
 by: Kohei Odajima, et al.
 Published: (2024-11-01)
 
       